What is driving sentiment for TriplePoint TPVG stock Q4 2025 Earnings Underperform Is Rein Therapeutics RNTX stock testing important levels Q4 2025 Profit Disappoints BSBR Santander BR reports sharp Q1 2023 EPS miss edges modestly higher as investors look past nearterm weakness